Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid added to neoadjuvant chemotherapy in invasive breast cancer
NCT00525759Phase 2Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Jul 2007
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zoledronic acid in breast cancer, sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Started Jul 2007; status: completed.
02
Drugs
zoledronic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00525759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00525759.